The International Pharmacopoeia
The International Pharmacopoeia (Ph. Int.) is a collection of quality specifications for pharmaceutical substances and dosage forms, together with supporting general methods of analysis. Its purpose is to serve as source material for reference or adaptation by any World Health Organization (WHO) Member State wishing to establish pharmaceutical requirements.
History[edit | edit source]
The International Pharmacopoeia was first published by the World Health Organization (WHO) in 1951. It was developed in response to the need for internationally harmonized specifications for pharmaceutical substances and dosage forms. The first edition contained only 28 monographs. Over the years, the publication has grown and the sixth edition, published in 2016, contains more than 400 monographs.
Purpose[edit | edit source]
The main purpose of The International Pharmacopoeia is to promote and protect public health. It does this by providing internationally recognized and accepted quality standards and specifications for pharmaceutical substances and dosage forms, along with associated analytical methods. These standards are used by regulatory authorities, pharmaceutical industries, and laboratories worldwide to ensure that medicines are of the required quality.
Content[edit | edit source]
The International Pharmacopoeia contains monographs for pharmaceutical substances and dosage forms, along with test methods, reagents, and apparatus that are necessary for implementing the monographs. The substances included are selected on the basis of worldwide use and importance. The monographs are developed through a consultative process involving WHO Member States, WHO Expert Committees, and partner organizations.
Use[edit | edit source]
The International Pharmacopoeia is used by national and regional regulatory authorities, pharmaceutical manufacturers, and quality control laboratories. It serves as a basis for national and regional pharmacopoeias and is used to establish national and regional standards for pharmaceutical substances and dosage forms.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
